Mycoplasma pneumonia is a common respiratory infection in Asian children that usually responds well to antibiotics. But researchers in China discovered that some children's infections linger much longer than expected—and a specific genetic mutation in the bacteria may be why.
The study looked at 279 hospitalised children with mycoplasma pneumonia. Those whose bacteria carried the A2063G mutation experienced significantly longer fevers, stayed in hospital longer, and required stronger anti-inflammatory medications (steroids) compared to children without this mutation.
The mutation makes pneumonia stubbornly slow, not severely sick
The key finding is subtle but important: the mutation doesn't make children dramatically sicker in the usual ways doctors measure. Standard blood tests like white blood cell counts and kidney function looked normal in both groups. Instead, the mutation makes the infection drag on. Children with the A2063G mutation experienced:
- Longer fever duration before recovery
- Extended hospital stays
- Higher rates of steroid use
- Elevated inflammation markers in blood (CRP, D-dimer, and LDH)
This means a child with this mutation might have a "normal-looking" infection that just won't go away.
Genetic testing could help your doctor plan better
If your child's mycoplasma pneumonia seems unusually persistent, asking about genetic testing of the bacteria could change how your paediatrician manages the case. Early identification of this mutation would let doctors prepare families for a longer recovery, adjust medication choices sooner, and potentially avoid unnecessary complications or extended hospitalisations.
This type of testing isn't yet routine in all Singapore hospitals, but it's a reasonable question to raise if your child isn't improving as expected after 1–2 weeks of standard treatment.
What to do if your child's recovery seems slow
- Ask your child's doctor about bacterial genetic testing if mycoplasma pneumonia symptoms persist beyond expected recovery time.
- Request a review of medication strength and anti-inflammatory options if fever and symptoms continue after initial treatment.
- Track recovery timeline so you can clearly describe the pattern to your doctor—this helps them decide whether further investigation is warranted.